A federal watchdog has used one extraordinary fraud allegation to expose a broader screening gap in Medicare Advantage. In a recent equipment case cited by auditors, bad actors were accused of billing more than $10 billion for durable medical equipment, prosthetics, orthotics and supplies. The figure describes alleged billings, not proven losses or money Medicare Advantage plans necessarily paid.
The $10 Billion Figure Comes From an HHS Watchdog
The Department of Health and Human Services Office of Inspector General published its issue brief on September 9. OIG said that in one recent case alone, defendants were accused of fraudulently billing Medicare for more than $10 billion in equipment and supplies. The report used that case as a scale marker while examining whether Medicare Advantage organizations and the Centers for Medicare and Medicaid Services screen the suppliers that bill private plans.
Free retirement updates: Keep more of your Social Security and savings with plain-English updates on the changes, deadlines, and costly mistakes retirees miss. Subscribe free.
Out-of-Network Suppliers Face Fewer Plan Checks
Medicare Advantage organizations screen suppliers in their networks because those businesses have a contractual relationship with the plan. OIG found that plans conduct fewer checks on out-of-network equipment suppliers. Yet those suppliers can still bill for covered services in some circumstances. That creates a weak point: the supplier with the least direct oversight may still submit large volumes of claims. Auditors did not say every out-of-network supplier is suspicious. Their concern was that the screening architecture leaves the riskiest lane less visible than the contracted network.
CMS Does Not Screen Every Supplier Before Billing Begins
Traditional Medicare generally requires equipment suppliers to enroll in Medicare, which subjects them to federal screening. In Medicare Advantage, not every supplier that bills a plan is enrolled in the federal program. OIG found that CMS therefore does not screen all suppliers before they begin billing Medicare Advantage. The agency also maintains a Preclusion List intended to stop certain problem providers and suppliers, but auditors said the list has limitations. A supplier operating out of network and outside Medicare enrollment can fall between plan-level and federal controls.
Auditors Recommended Closing the Enrollment Gap
OIG made three recommendations. It called for stronger plan checks on out-of-network suppliers, better use of the Preclusion List and a requirement that all equipment suppliers billing Medicare Advantage enroll in Medicare, or that CMS seek statutory authority if it lacks power to impose that requirement. CMS concurred or said it would consider the recommendations. The report is final, but the recommendations are not equivalent to a new rule already in force. Their significance lies in defining a concrete path from the discovered vulnerability to a more uniform screening system.
Claims Data Can Reveal Patterns That One Patient Cannot See
Equipment fraud often relies on identifiers gathered from beneficiaries and orders attributed to clinicians who may have little connection to the patient. An individual explanation of benefits can show an unfamiliar brace, dressing or device, but it cannot reveal a supplier submitting the same pattern across thousands of members. Plans and CMS hold that larger view. Comparing billing spikes, addresses, prescribing relationships and enrollment status can expose conduct that looks ordinary on a single claim. The OIG report argues that those analytics work best when every supplier enters through a screened door.
The Headline Describes Billing, Not a $10 Billion Payout
Large fraud cases often carry several numbers: claims submitted, claims approved, money disbursed and loss calculated for sentencing. The OIG brief uses “billing” and “accused,” so it places the $10 billion at the first stage and preserves the allegation posture. Nothing in the report says plans paid all of it. That distinction is financially substantial because automated systems can reject, suspend or recoup claims before they become a final program loss. It is also legally necessary because defendants retain the presumption of innocence until guilt is established. The case serves as evidence of potential scale and urgency behind the screening recommendations, not as a final audit finding that $10 billion disappeared from Medicare.
The brief does not identify the case by name in its summary, so the audit itself is the controlling source for the figure used here. Adding a defendant, payment total or conviction status from a different matter would create a false composite. The supported claim is deliberately narrow: one recent case alleged billings above $10 billion. This wording keeps the allegation tied to the audited record.
Benefit Programs Beyond Equipment Billing
The fraud-screening gap concerns claims paid to suppliers, not assistance available to households. Separately, Medicare Savings Programs, Extra Help and state drug-assistance programs remain opt-in benefits with separate income tests.
The Benefits Checklist lays out 11 programs in 69 pages, with 2026 limits and a 50-state phone directory.
Compare those household programs in The Benefits Checklist.
AI tools assisted in researching and drafting this article, which was reviewed prior to publication.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
